🇺🇸 FDA
Patent

US 9676771

Compounds for inhibiting drug-resistant strains of HIV-1 integrase

granted A61KA61K31/4375A61K31/4704

Quick answer

US patent 9676771 (Compounds for inhibiting drug-resistant strains of HIV-1 integrase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4375, A61K31/4704, A61K31/496, A61K31/5377